FDA Grants Fast Track Designation to VCN-01 in Metastatic Pancreatic Cancer

VCN-01 plus gemcitabine and nab-paclitaxel has received fast track designation from the FDA in metastatic pancreatic adenocarcinoma.

Related Keywords

United States ,Theriva Biologics ,Stevena Shallcross ,